APPLICATION
NDA005914
TYPE
NDA
ORIGINAL APPROVAL
1948-02-19
LATEST ACTION
1999-04-23
ROUTE
ORAL
DOSAGE FORM
ELIXIR, TABLET
MARKETING STATUS
Discontinued
Products
PBZDiscontinued
TRIPELENNAMINE CITRATE EQ 25MG HYDROCHLORIDE/5ML · ELIXIR · ORAL
PBZDiscontinued
TRIPELENNAMINE HYDROCHLORIDE 50MG · TABLET · ORAL
Approval history
1999-04-23Manufacturing (CMC) · Supplement 38 · standardAP
1998-03-24Efficacy · Supplement 30AP
1948-02-19Type 1 - New Molecular Entity · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.